Demir, Münevver

Complement activation induces excessive T cell cytotoxicity in severe COVID-19

Georg, P., Astaburuaga-García, R., Bonaguro, L., Brumhard, S., Michalick, L., Lippert, L. J., Kostevc, T., Gäbel, C., Schneider, M., Streitz, M., et al. (2022) · Cell

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 218

The fecal mycobiome in non-alcoholic fatty liver disease

Demir, M., Lang, S., Hartmann, P., Duan, Y., Martin, A., Miyamoto, Y., Bondareva, M., Zhang, X., Wang, Y., Kasper, P., et al. (2022) · Journal of Hepatology

Gut microbiota and healthLiver Disease Diagnosis and Treatment

Cited by 197

Nonalcoholic fatty liver disease – current status and future directions

Demir, M., Lang, S., & Steffen, H. (2015) · Journal of Digestive Diseases

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 105

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial

Traussnigg, S., Schattenberg, J. M., Demir, M., Wiegand, J., Geier, A., Teuber, G., Hofmann, W. P., Kremer, A. E., Spreda, F., Kluwe, J., et al. (2019) · The Lancet Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 88

Skeletal Muscle Composition Predicts Outcome in Critically Ill Patients

Loosen, S. H., Schulze-Hagen, M., Püngel, T., Bündgens, L., Wirtz, T., Kather, J. N., Vucur, M., Paffenholz, P., Demir, M., Bruners, P., et al. (2020) · Critical Care Explorations

Nutrition and Health in AgingClinical Nutrition and Gastroenterology

Cited by 58